Fwd: Scholar Alert - [ multiple sclerosis ]

[Guest guest]

new academic research on ms.. don't know if these will help anyone..

Yvette

---------- Forwarded message ----------

Date: Fri, Nov 19, 2010 at 9:58 PM

Subject: Scholar Alert - [ " multiple sclerosis " ]

To: atlanteanproductions@...

*Scholar Alert: [ " multiple sclerosis " ]*

… progressive versus relapsing-onset *multiple sclerosis*: presence and

prognostic

…<http://scholar.google.com/scholar_url?hl=en & q=http://msj.sagepub.com/content\

/early/2010/11/13/1352458510386996.abstract & oi=scholaralrt & ct=alrt & cd=0 & sa=X & sci\

sig=AAGBfm22uzz32tO0RLGe7tRyNDrHBkOx6w>

P

Sola, J Mandrioli, AM Simone, D Ferraro… - *Multiple Sclerosis*, 2010

Abstract Background: There is increasing evidence on cerebrospinal fluid

(CSF) oligoclonal

IgM (OCIgM) predicting a more aggressive disease course in

relapsing–remitting *Multiple Sclerosis*

(MS), while there is a scarcity of data for primary progressive MS (PPMS).

Objective: Our * ...*

… acetate-specific T cells isolated from *multiple sclerosis *patient

receiving the drug

…<http://scholar.google.com/scholar_url?hl=en & q=http://linkinghub.elsevier.com\

/retrieve/pii/S0198885910005306 & oi=scholaralrt & ct=alrt & cd=1 & sa=X & scisig=AAGBfm0C\

RbPMI6jWU8sCFoFCS10Uz-EU2A>

RA

Hoglund, AL Hestvik, T Holmoy… - Human Immunology, 2010

The purpose of the current study is to examine the surface expression of

chemokine receptors

and the chemotaxis toward the respective chemokines of glatiramer acetate

(GA)–specific CD4

+ T cells isolated from the blood and the cerebrospinal fluid (CSF) of

a *multiple

sclerosis ...*

[PDF] Walking impairment in patients with *multiple sclerosis*: exercise

training as a

…<http://scholar.google.com/scholar_url?hl=en & q=http://www.dovepress.com/getfi\

le.php%3FfileID%3D8113 & oi=scholaralrt & ct=alrt & cd=2 & sa=X & scisig=AAGBfm3yMUkcyJ9hm\

Z8QbwiYUV8bweYuEA>

RW

Motl, MD Goldman… - Neuropsychiatric Disease and Treatment, 2010

© 2010 Motl et al, publisher and licensee Dove Medical Press Ltd. This is an

Open Access article

which permits unrestricted noncommercial use, provided the original work is

properly cited. * ...*

w Motl1 Myla D Goldman2 Ralph HB Benedict3 * ...* 1Department of

Kinesiology * ...*

… quality of life in relapsing remitting *multiple sclerosis *patients

during treatment with

…<http://scholar.google.com/scholar_url?hl=en & q=http://www.hqlo.com/content/8/\

1/133/abstract & oi=scholaralrt & ct=alrt & cd=3 & sa=X & scisig=AAGBfm1dUJEr9cqKOCP82rrV0\

7GXgue8_w>

PJ

Jongen, D Lehnick, E , P Seeldrayers… - Health and Quality of Life …,

2010

At 6 and 12 months mean LMS-QoL scores were significantly increased in the

treatment-naive

patient group (p<0.001), not in the pre-treated group. At month 12 43% of

treatment-naive patients

had improved HR-QoL (increase LMS-QoL score 3 or more points) (p<0.001).

Likewise, * ...*

… management of symptoms in *multiple sclerosis*: current approaches and

future

…<http://scholar.google.com/scholar_url?hl=en & q=http://linkinghub.elsevier.com\

/retrieve/pii/S1474442210702490 & oi=scholaralrt & ct=alrt & cd=4 & sa=X & scisig=AAGBfm2u\

ZklTzw2QAGwZko4kc6qToVOVRw>

AJ

, AT Toosy… - The Lancet Neurology, 2010

Management of symptoms in *multiple sclerosis* (MS) has received little

attention compared with

disease-modifying treatments. However, the effect of these symptoms on

quality of life can be

profound. Clinical trials of pharmacological drugs to treat symptoms of MS

have often * ...*

Pregnancy and fetal outcomes after interferon-β exposure in *multiple

sclerosis*<http://scholar.google.com/scholar_url?hl=en & q=http://www.neurology.or\

g/content/75/20/1794.abstract & oi=scholaralrt & ct=alrt & cd=5 & sa=X & scisig=AAGBfm2WuZ\

y2mWPHCQdFrB9tDrnH-JINbg>

MP

Amato, E Portaccio, A Ghezzi, B Hakiki… - Neurology, 2010

DOI 10.1212/WNL.0b013e3181fd62bb 2010;75;1794 Neurology MP Amato, E.

Portaccio, A.

Ghezzi, et al. *multiple sclerosis* exposure in β * ...* November 17, 2010

This information is current

as of * ...* MP Amato, MD E. Portaccio, MD A. Ghezzi, MD B. Hakiki, MD V.

Zipoli, MD V. * ...*

Controversial Role of Epstein-Barr Virus in *Multiple

Sclerosis*<http://scholar.google.com/scholar_url?hl=en & q=http://pdfs.journals.lw\

w.com/appliedimmunohist/9000/00000/Controversial_Role_of_Epstein_Barr_Virus_in.9\

9708.pdf & oi=scholaralrt & ct=alrt & cd=6 & sa=X & scisig=AAGBfm2LIixZKRTQmvkA61q4_JFyqCI\

t4w>

N

Fatima, MP Toscano, SB Hunter… - Applied Immunohistochemistry & …, 2010

Abstract: The role of Epstein-Barr virus (EBV) in the pathogenesis of *multiple

sclerosis* (MS) is

still elusive. In 2007, Serafini et al demonstrated the direct role of EBV

in brain lesions of MS

patients. They found positive immunohistochem- istry (IHC) staining for

latency * ...*

[PDF] Congenital Abnormalities and *Multiple

Sclerosis*<http://scholar.google.com/scholar_url?hl=en & q=http://www.biomedcentra\

l.com/content/pdf/1471-2377-10-115.pdf & oi=scholaralrt & ct=alrt & cd=7 & sa=X & scisig=A\

AGBfm2lddlF7VxpN4qa79TAJEUcs4ZqUg>

S

Ramagopalan, C Guimond, M Criscuoli… - BMC Neurology, 2010

Sreeram V Ramagopalan (sramagopalan@...) Colleen Guimond

(cguimond@...) Criscuoli (

mcriscuoli@...)

A Dyment (ddyment@...) - Orton (ortons@...)

Irene M * ...*

MGAT5 and disease severity in progressive *multiple

sclerosis*<http://scholar.google.com/scholar_url?hl=en & q=http://linkinghub.elsev\

ier.com/retrieve/pii/S0165572810004765 & oi=scholaralrt & ct=alrt & cd=8 & sa=X & scisig=A\

AGBfm06r0RBo3zu6A0Vxgr_tjoa1YRQdg>

F

Esposito, J Wojcik, M Rodegher, M Radaelli… - Journal of …, 2010

MGAT5 was demonstrated to be associated to *multiple sclerosis* (MS)

severity. We evaluated

its role in progressive MS. We studied 11 SNPs mapping to MGAT5 in an

Italian cohort of primary

progressive or progressive-relapsing patients. The rs1257169G allele is

associated with * ...*

TGF-β signaling is altered in the peripheral blood of subjects with *multiple

sclerosis*<http://scholar.google.com/scholar_url?hl=en & q=http://linkinghub.elsev\

ier.com/retrieve/pii/S0165572810004789 & oi=scholaralrt & ct=alrt & cd=9 & sa=X & scisig=A\

AGBfm1bVVuyqvpI_xetCQz-zcAr9SaqJw>

EM

Meoli, U Oh, CW Grantinn… - Journal of Neuroimmunology, 2010

*Multiple sclerosis* (MS) is a central nervous system inflammatory disorder

with evidence of peripheral

immune dysregulation. Abnormalities of the immune suppressive cytokine TGF-β

have been

reported, but not fully defined, in MS. Through a pathway-focused expression

profiling of * ...*

------------------------------

This Google Scholar Alert is brought to you by Google.

Cancel

alert<http://scholar.google.com/scholar_alerts?view_op=cancel_alert_options & emai\

l_for_op=atlanteanproductions%40gmail.com & alert_id=ScJXhxH0hf8J & hl=en>

List

alerts<http://scholar.google.com/scholar_alerts?view_op=list_alerts & email_for_op\

=atlanteanproductions%40gmail.com & alert_id=ScJXhxH0hf8J & hl=en>

--

Yvette

Freelance Writer

[Guest guest]

new academic research on ms.. don't know if these will help anyone..

Yvette

---------- Forwarded message ----------

Date: Fri, Nov 19, 2010 at 9:58 PM

Subject: Scholar Alert - [ " multiple sclerosis " ]

To: atlanteanproductions@...

*Scholar Alert: [ " multiple sclerosis " ]*

… progressive versus relapsing-onset *multiple sclerosis*: presence and

prognostic

…<http://scholar.google.com/scholar_url?hl=en & q=http://msj.sagepub.com/content\

/early/2010/11/13/1352458510386996.abstract & oi=scholaralrt & ct=alrt & cd=0 & sa=X & sci\

sig=AAGBfm22uzz32tO0RLGe7tRyNDrHBkOx6w>

P

Sola, J Mandrioli, AM Simone, D Ferraro… - *Multiple Sclerosis*, 2010

Abstract Background: There is increasing evidence on cerebrospinal fluid

(CSF) oligoclonal

IgM (OCIgM) predicting a more aggressive disease course in

relapsing–remitting *Multiple Sclerosis*

(MS), while there is a scarcity of data for primary progressive MS (PPMS).

Objective: Our * ...*

… acetate-specific T cells isolated from *multiple sclerosis *patient

receiving the drug

…<http://scholar.google.com/scholar_url?hl=en & q=http://linkinghub.elsevier.com\

/retrieve/pii/S0198885910005306 & oi=scholaralrt & ct=alrt & cd=1 & sa=X & scisig=AAGBfm0C\

RbPMI6jWU8sCFoFCS10Uz-EU2A>

RA

Hoglund, AL Hestvik, T Holmoy… - Human Immunology, 2010

The purpose of the current study is to examine the surface expression of

chemokine receptors

and the chemotaxis toward the respective chemokines of glatiramer acetate

(GA)–specific CD4

+ T cells isolated from the blood and the cerebrospinal fluid (CSF) of

a *multiple

sclerosis ...*

[PDF] Walking impairment in patients with *multiple sclerosis*: exercise

training as a

…<http://scholar.google.com/scholar_url?hl=en & q=http://www.dovepress.com/getfi\

le.php%3FfileID%3D8113 & oi=scholaralrt & ct=alrt & cd=2 & sa=X & scisig=AAGBfm3yMUkcyJ9hm\

Z8QbwiYUV8bweYuEA>

RW

Motl, MD Goldman… - Neuropsychiatric Disease and Treatment, 2010

© 2010 Motl et al, publisher and licensee Dove Medical Press Ltd. This is an

Open Access article

which permits unrestricted noncommercial use, provided the original work is

properly cited. * ...*

w Motl1 Myla D Goldman2 Ralph HB Benedict3 * ...* 1Department of

Kinesiology * ...*

… quality of life in relapsing remitting *multiple sclerosis *patients

during treatment with

…<http://scholar.google.com/scholar_url?hl=en & q=http://www.hqlo.com/content/8/\

1/133/abstract & oi=scholaralrt & ct=alrt & cd=3 & sa=X & scisig=AAGBfm1dUJEr9cqKOCP82rrV0\

7GXgue8_w>

PJ

Jongen, D Lehnick, E , P Seeldrayers… - Health and Quality of Life …,

2010

At 6 and 12 months mean LMS-QoL scores were significantly increased in the

treatment-naive

patient group (p<0.001), not in the pre-treated group. At month 12 43% of

treatment-naive patients

had improved HR-QoL (increase LMS-QoL score 3 or more points) (p<0.001).

Likewise, * ...*

… management of symptoms in *multiple sclerosis*: current approaches and

future

…<http://scholar.google.com/scholar_url?hl=en & q=http://linkinghub.elsevier.com\

/retrieve/pii/S1474442210702490 & oi=scholaralrt & ct=alrt & cd=4 & sa=X & scisig=AAGBfm2u\

ZklTzw2QAGwZko4kc6qToVOVRw>

AJ

, AT Toosy… - The Lancet Neurology, 2010

Management of symptoms in *multiple sclerosis* (MS) has received little

attention compared with

disease-modifying treatments. However, the effect of these symptoms on

quality of life can be

profound. Clinical trials of pharmacological drugs to treat symptoms of MS

have often * ...*

Pregnancy and fetal outcomes after interferon-β exposure in *multiple

sclerosis*<http://scholar.google.com/scholar_url?hl=en & q=http://www.neurology.or\

g/content/75/20/1794.abstract & oi=scholaralrt & ct=alrt & cd=5 & sa=X & scisig=AAGBfm2WuZ\

y2mWPHCQdFrB9tDrnH-JINbg>

MP

Amato, E Portaccio, A Ghezzi, B Hakiki… - Neurology, 2010

DOI 10.1212/WNL.0b013e3181fd62bb 2010;75;1794 Neurology MP Amato, E.

Portaccio, A.

Ghezzi, et al. *multiple sclerosis* exposure in β * ...* November 17, 2010

This information is current

as of * ...* MP Amato, MD E. Portaccio, MD A. Ghezzi, MD B. Hakiki, MD V.

Zipoli, MD V. * ...*

Controversial Role of Epstein-Barr Virus in *Multiple

Sclerosis*<http://scholar.google.com/scholar_url?hl=en & q=http://pdfs.journals.lw\

w.com/appliedimmunohist/9000/00000/Controversial_Role_of_Epstein_Barr_Virus_in.9\

9708.pdf & oi=scholaralrt & ct=alrt & cd=6 & sa=X & scisig=AAGBfm2LIixZKRTQmvkA61q4_JFyqCI\

t4w>

N

Fatima, MP Toscano, SB Hunter… - Applied Immunohistochemistry & …, 2010

Abstract: The role of Epstein-Barr virus (EBV) in the pathogenesis of *multiple

sclerosis* (MS) is

still elusive. In 2007, Serafini et al demonstrated the direct role of EBV

in brain lesions of MS

patients. They found positive immunohistochem- istry (IHC) staining for

latency * ...*

[PDF] Congenital Abnormalities and *Multiple

Sclerosis*<http://scholar.google.com/scholar_url?hl=en & q=http://www.biomedcentra\

l.com/content/pdf/1471-2377-10-115.pdf & oi=scholaralrt & ct=alrt & cd=7 & sa=X & scisig=A\

AGBfm2lddlF7VxpN4qa79TAJEUcs4ZqUg>

S

Ramagopalan, C Guimond, M Criscuoli… - BMC Neurology, 2010

Sreeram V Ramagopalan (sramagopalan@...) Colleen Guimond

(cguimond@...) Criscuoli (

mcriscuoli@...)

A Dyment (ddyment@...) - Orton (ortons@...)

Irene M * ...*

MGAT5 and disease severity in progressive *multiple

sclerosis*<http://scholar.google.com/scholar_url?hl=en & q=http://linkinghub.elsev\

ier.com/retrieve/pii/S0165572810004765 & oi=scholaralrt & ct=alrt & cd=8 & sa=X & scisig=A\

AGBfm06r0RBo3zu6A0Vxgr_tjoa1YRQdg>

F

Esposito, J Wojcik, M Rodegher, M Radaelli… - Journal of …, 2010

MGAT5 was demonstrated to be associated to *multiple sclerosis* (MS)

severity. We evaluated

its role in progressive MS. We studied 11 SNPs mapping to MGAT5 in an

Italian cohort of primary

progressive or progressive-relapsing patients. The rs1257169G allele is

associated with * ...*

TGF-β signaling is altered in the peripheral blood of subjects with *multiple

sclerosis*<http://scholar.google.com/scholar_url?hl=en & q=http://linkinghub.elsev\

ier.com/retrieve/pii/S0165572810004789 & oi=scholaralrt & ct=alrt & cd=9 & sa=X & scisig=A\

AGBfm1bVVuyqvpI_xetCQz-zcAr9SaqJw>

EM

Meoli, U Oh, CW Grantinn… - Journal of Neuroimmunology, 2010

*Multiple sclerosis* (MS) is a central nervous system inflammatory disorder

with evidence of peripheral

immune dysregulation. Abnormalities of the immune suppressive cytokine TGF-β

have been

reported, but not fully defined, in MS. Through a pathway-focused expression

profiling of * ...*

------------------------------

This Google Scholar Alert is brought to you by Google.

Cancel

alert<http://scholar.google.com/scholar_alerts?view_op=cancel_alert_options & emai\

l_for_op=atlanteanproductions%40gmail.com & alert_id=ScJXhxH0hf8J & hl=en>

List

alerts<http://scholar.google.com/scholar_alerts?view_op=list_alerts & email_for_op\

=atlanteanproductions%40gmail.com & alert_id=ScJXhxH0hf8J & hl=en>

--

Yvette

Freelance Writer